Talant MA Sooronbaev, Prof. Dr.
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jingxin Cao
Tibet Fokind Hospital
Shared therapeutic areas:
Trond-Eirik Strand, M.D., Ph.D.
Institute of Aviation Medicine, Norwegian Armed Forces Medical
Shared therapeutic areas:
Talant M Sooronbaev, MD
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Shared therapeutic areas:
Worked with same sponsors:
Talant M Sooronbaev, MD
NCCIM
Shared therapeutic areas:
Worked with same sponsors:
Talant M Sooronbaev, Prof. Dr.
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
Shared therapeutic areas:
Worked with same sponsors:
Talant Sooronbaev, MD
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
Shared therapeutic areas:
Worked with same sponsors:
Konrad E Bloch, MD
University of Zurich, Switzerland
Shared therapeutic areas:
Worked with same sponsors:
Thies Schroeder, Ph.D.
Department of Radiation Oncology, Duke University Medical Center
Shared therapeutic areas:
Silvia Ulrich, Prof. Dr.
University Hospital Zurich, Department of Pulmonology
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)
Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)
All 2 trials loaded